Since 2012, we have supported hundreds of studies for oligonucleotide-based drugs, including: qualification, full method validation and GLP sample analysis studies for oligonucleotide-based drugs, in tissue and plasma for preclinical and clinical studies.
What Sets Us Apart?
• Partnered with recognized global leaders in RNA-targeted discoveries
•Nearly 100 individual compounds successfully validated since 2012
•Vast experience with chemically modified oligonucleotides including GalNAc conjugate, cholesterol conjugate, thymidylic acid and phosphate
Method transfer, development & qualification, Full validation, Quantitative bioanalysis, Metabolite ID & confirmation
Plasma/Serum, Urine, CSF, Muscle, Liver, Kidney, Lung, Brain, Heart, Tumor Tissue, PBMC, Ocular
Bioanalysis for non-clinical and clinical stages of drug development